Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Boehringer Ingelheim USA Corporation

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTN

Phase 4

Completed

Conditions: Hypertension

First Posted Date: 2006-01-11

Last Posted Date: 2023-12-06

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 812

Registration Number: NCT00274599

Locations: 🇺🇸
Spartanburg Medical Research, Spartanburg, South Carolina, United States
🇺🇸
Harold B. Betton, M.D., Little Rock, Arkansas, United States
🇺🇸
GFI Pharmaceuticals, Evansville, Indiana, United States

and more 7 locations

Effects of Once Daily Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) of Different Severity

Phase 3

Completed

Conditions: Pulmonary Disease, Chronic Obstructive

First Posted Date: 2006-01-11

Last Posted Date: 2013-11-21

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 1639

Registration Number: NCT00274573

Locations: 🇩🇪
Boehringer Ingelheim Investigational Site, Zwickau, Germany
🇩🇪
MEDARS GmbH, Berlin, Germany
🇩🇪
Johannes-Gutenberg-Universität Mainz, Mainz, Germany

Effect of Tiotropium (Spiriva) on Exercise Tolerance in COPD Patients

Phase 3

Completed

Conditions: Pulmonary Disease, Chronic Obstructive

First Posted Date: 2006-01-11

Last Posted Date: 2023-12-01

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 261

Registration Number: NCT00274508

Locations: 🇺🇸
St. Thomas Health Services, Nashville, Tennessee, United States
🇺🇸
Presbyterian Hospital of Dallas, Dallas, Texas, United States
🇨🇦
Department of Respiratory Medicine, Toronto, Ontario, Canada

and more 21 locations

PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)

Phase 4

Completed

Conditions: Hypertension

First Posted Date: 2006-01-11

Last Posted Date: 2013-12-09

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 805

Registration Number: NCT00274638

Locations: 🇺🇸
Herron Medical Center, Ltd., Chicago, Illinois, United States
🇺🇸
Midwest Institute for Clinical Research Inc., Indianapolis, Indiana, United States
🇺🇸
nTouch Research, Houston, Texas, United States

and more 50 locations

A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol.

Phase 3

Completed

Conditions: Pulmonary Disease, Chronic Obstructive

First Posted Date: 2006-01-11

Last Posted Date: 2023-12-01

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 653

Registration Number: NCT00274560

Locations: 🇺🇸
Temple University School of Medicine, Philadelphia, Pennsylvania, United States
🇬🇷
University Hospital of Ioannina, Ioannina, Greece
🇺🇸
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

and more 32 locations

Mechanisms of Dyspnea Relief During Exercise in COPD Patients Following Treatment With Tiotropium (Spiriva)

Phase 3

Completed

Conditions: Pulmonary Disease, Chronic Obstructive

First Posted Date: 2006-01-10

Last Posted Date: 2013-11-01

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 19

Registration Number: NCT00274027

Locations: 🇨🇦
Kingston General Hospital, Kingston, Ontario, Canada

Acute Bronchodilator Response of a Single Dose of Atrovent or Berotec on Top of Pharmacodynamic Steady State of Spiriva

Phase 3

Completed

Conditions: Pulmonary Disease, Chronic Obstructive

First Posted Date: 2006-01-10

Last Posted Date: 2013-11-01

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 65

Registration Number: NCT00274066

Locations: 🇳🇱
Afdeling longziekten, Winschoten, Netherlands
🇳🇱
Twenteborg Ziekenhuis, Almelo, Netherlands
🇳🇱
Amphia Ziekenhuis, Breda, Netherlands

and more 2 locations

Inflammation and Coronary Artery Disease: Role of AT1-Receptor Antagonism

Phase 4

Completed

Conditions: Hypertension
Coronary Arteriosclerosis

First Posted Date: 2006-01-10

Last Posted Date: 2013-11-01

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 42

Registration Number: NCT00274144

Locations: 🇩🇪
Universitätsklinik des Saarlandes, Homburg/Saar, Germany

Quality of Life and Changes in Metabolism of Lipids and Glucose After Switching to a Nevirapine-based Regimen in HIV+ Patients

Phase 4

Completed

Conditions: Quality of Life
HIV Infections

First Posted Date: 2006-01-10

Last Posted Date: 2013-11-01

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 158

Registration Number: NCT00274001

Locations: 🇮🇹
Ospedale degli Infermi di Biella, Biella, Italy
🇮🇹
Ospedale Civile, Piacenza, Italy
🇮🇹
Spedali Civili di Brescia, Brescia, Italy

and more 19 locations

Comparison of Tiotropium and Ipratropium in a Double-Blind, Double-dummy, Efficacy and Safety Study in Adults With COPD

Phase 3

Completed

Conditions: Pulmonary Disease, Chronic Obstructive

First Posted Date: 2006-01-10

Last Posted Date: 2013-11-01

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 141

Registration Number: NCT00274040

Locations: 🇰🇷
Chung-ang University Hospital, Seoul, Korea, Republic of
🇰🇷
Kangnam St. Mary's Hospital, Seoul, Korea, Republic of
🇰🇷
Jeonnam National University Hospital, Kwangju, Korea, Republic of

and more 15 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy